Precision medicine is reshaping oncology, yet gaps in testing, coverage, and care delivery still prevent many patients from receiving the right therapy at the right time. In this episode of Unscripted, AMCP’s Mitzi Wasik and Chief Science Officer Cate Lockhart discuss where fragmentation occurs across the health care system and why pharmacists, payers, providers, and pathologists all play a critical role in fixing it. They unpack challenges around guideline alignment, defining clinical utility, and payer decision-making, while also highlighting the growing momentum: stronger cross-sector collaboration, expanding education efforts, and new tools designed to bring more consistency, equity, and evidence-based access to precision oncology.